Apnea of prematurity
Apnea of prematurity is common in neonates born before 32 weeks gestation or weighing less than 1000g, with rates as high as 54% in infants born at 30-31 weeks and nearly 100% in infants born below 29 weeks or weighing less than 1000g. Apnea can be classified as central, obstructive, or mixed based on whether there is absence of respiratory effort or upper airway obstruction. Common causes include infection, neurological or cardiovascular issues, pulmonary problems, inborn errors of metabolism, metabolic or hematological conditions, gastrointestinal issues, problems with temperature regulation, and drugs. Evaluation may include investigations and treatment involves general measures as well as specific measures and emergency treatment if needed. Methylxanthines are commonly
Apnea of prematurity
- 1. M.D.(Paed) D.N.B KIMSDU KARAD DR CHANDRASHEKHAR AUNDHAKAR
- 2. Apnea of Prematurity • 7 % of neonates with GA of 34-35weeks • 15% of neonates with GA of 32-33weeks • 54% of neonates with GA of 30-31 weeks • Nearly 100% neonates with GA of < 29 weeks or weight < 1000gm
- 6. Apnea is classified into three categories based on the presence or absence of upper airway obstruction:
- 9. Mixed Apnea
- 10. Apnea of Prematurity Periodic Breathing Apnea of Prematurity swallowing movements
- 11. Causes of Apnea ( AllTypes) • Infection • Neurological • Cardiovascular • Pulmonary • Inborn Errors of Metabolism
- 12. Causes of Apnea ( AllTypes) • Metabolic • Hematological • Gastrointestinal • Temperature Regulation • Drugs
- 13. Evaluation of a child with apnoea Investigations
- 14. Treatment of apnoea General measures Specific measures
- 16. Key determinants in choosing the appropriate drug.
- 17. Methylxanthines
- 18. Maior Effects of Methylxanthines
- 20. Methylxanthines
- 22. Surveillance AOP